Healthcare provider profile · identity verified

Hima B. Illindala, MD

Internal Medicine · LAS VEGAS, NV · NPI 1083604102

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	474	146
Atorvastatin Calcium	Atorvastatin Calcium	420	133
Amlodipine Besylate	Amlodipine Besylate	387	135
Losartan Potassium	Losartan Potassium	379	118
Alprazolam	Alprazolam	239	65
Rosuvastatin Calcium	Rosuvastatin Calcium	221	84
Lisinopril	Lisinopril	216	72
Omeprazole	Omeprazole	197	79
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	195	44
Escitalopram Oxalate	Escitalopram Oxalate	182	62
Simvastatin	Simvastatin	174	59
Trazodone Hcl	Trazodone Hcl	173	63
Gabapentin	Gabapentin	161	60
Metformin Hcl	Metformin Hcl	149	47
Metoprolol Succinate	Metoprolol Succinate	140	48
Fluticasone Propionate	Fluticasone Propionate	138	74
Tizanidine Hcl	Tizanidine Hcl	131	62
Pravastatin Sodium	Pravastatin Sodium	123	37
Metoprolol Tartrate	Metoprolol Tartrate	113	45
Furosemide	Furosemide	110	50
Allopurinol	Allopurinol	105	32
Hydrochlorothiazide	Hydrochlorothiazide	100	42
Tamsulosin Hcl	Tamsulosin Hcl	98	36
Diazepam	Diazepam	90	21
Albuterol Sulfate Hfa	Albuterol Sulfate	89	42
Quetiapine Fumarate	Quetiapine Fumarate	89	33
Pantoprazole Sodium	Pantoprazole Sodium	84	32
Montelukast Sodium	Montelukast Sodium	83	30
Atenolol	Atenolol	82	29
Zolpidem Tartrate	Zolpidem Tartrate	82	22
Alendronate Sodium	Alendronate Sodium	81	34
Donepezil Hcl	Donepezil Hcl	80	31
Ciprofloxacin Hcl	Ciprofloxacin Hcl	78	67
Lovastatin	Lovastatin	78	22
Azithromycin	Azithromycin	77	62
Prednisone	Prednisone	77	62
Tramadol Hcl	Tramadol Hcl	73	37
Potassium Chloride	Potassium Chloride	72	26
Carvedilol	Carvedilol	71	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	68	16
Oxycodone Hcl	Oxycodone Hcl	64	suppressed
Clonazepam	Clonazepam	62	12
Famotidine	Famotidine	60	28
Ipratropium Bromide	Ipratropium Bromide	59	37
Clopidogrel	Clopidogrel Bisulfate	58	21
Metformin Hcl Er	Metformin Hcl	53	19
Oxybutynin Chloride	Oxybutynin Chloride	53	24
Methylprednisolone	Methylprednisolone	50	35
Clonidine Hcl	Clonidine Hcl	47	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	16
Dicyclomine Hcl	Dicyclomine Hcl	45	14
Glimepiride	Glimepiride	45	13
Eliquis	Apixaban	44	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	14
Duloxetine Hcl	Duloxetine Hcl	42	15
Meloxicam	Meloxicam	42	15
Finasteride	Finasteride	41	14
Triamcinolone Acetonide	Triamcinolone Acetonide	40	32
Hydralazine Hcl	Hydralazine Hcl	39	16
Ibuprofen	Ibuprofen	39	17
Memantine Hcl	Memantine Hcl	39	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	38	suppressed
Fenofibrate	Fenofibrate	38	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	11
Meclizine Hcl	Meclizine Hcl	38	27
Lorazepam	Lorazepam	36	suppressed
Ondansetron Odt	Ondansetron	36	19
Sertraline Hcl	Sertraline Hcl	36	13
Cephalexin	Cephalexin	35	26
Irbesartan	Irbesartan	35	suppressed
Valacyclovir	Valacyclovir Hcl	35	17
Baclofen	Baclofen	34	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	26
Methocarbamol	Methocarbamol	31	13
Pregabalin	Pregabalin	31	suppressed
Ezetimibe	Ezetimibe	30	11
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Ozempic	Semaglutide	27	11
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Spironolactone	Spironolactone	26	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Xarelto	Rivaroxaban	26	13
Liothyronine Sodium	Liothyronine Sodium	25	suppressed
Acyclovir	Acyclovir	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	11
Primidone	Primidone	23	suppressed
Linzess	Linaclotide	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	19
Gemfibrozil	Gemfibrozil	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Megestrol Acetate	Megestrol Acetate	18	12
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Amoxicillin	Amoxicillin	16	11
Fluconazole	Fluconazole	16	13
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Estradiol	Estradiol	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Minoxidil	Minoxidil	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Levetiracetam	Levetiracetam	14	suppressed
Prolia	Denosumab	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Cefuroxime	Cefuroxime Axetil	13	13
Risperidone	Risperidone	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error